Go Pro

BrightSpring Health Services (BTSG) Competitors

BrightSpring Health Services logo
$59.54 -0.72 (-1.19%)
As of 09:58 AM Eastern
This is a fair market value price provided by Massive. Learn more.

BTSG vs. LH, DGX, GH, FMS, and DVA

Should you buy BrightSpring Health Services stock or one of its competitors? BrightSpring Health Services's main competitors and comparable companies include Labcorp (LH), Quest Diagnostics (DGX), Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), and DaVita (DVA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does BrightSpring Health Services compare to Labcorp?

Labcorp (NYSE:LH) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations, institutional ownership and media sentiment.

Labcorp presently has a consensus target price of $330.00, suggesting a potential downside of 0.72%. BrightSpring Health Services has a consensus target price of $70.71, suggesting a potential upside of 18.50%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, analysts clearly believe BrightSpring Health Services is more favorable than Labcorp.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Labcorp
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.75
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
18 Buy rating(s)
2 Strong Buy rating(s)
3.10

Labcorp has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.85, meaning that its share price is 85% more volatile than the broader market.

95.9% of Labcorp shares are held by institutional investors. 0.8% of Labcorp shares are held by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Labcorp has higher earnings, but lower revenue than BrightSpring Health Services. Labcorp is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Labcorp$13.95B1.93$876.50M$12.0927.49
BrightSpring Health Services$14.37B0.82$190.67M$1.6635.94

Labcorp has a net margin of 6.99% compared to BrightSpring Health Services' net margin of 2.55%. Labcorp's return on equity of 16.74% beat BrightSpring Health Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Labcorp6.99% 16.74% 7.81%
BrightSpring Health Services 2.55%16.73%5.24%

In the previous week, BrightSpring Health Services had 6 more articles in the media than Labcorp. MarketBeat recorded 12 mentions for BrightSpring Health Services and 6 mentions for Labcorp. BrightSpring Health Services' average media sentiment score of 1.43 beat Labcorp's score of 0.75 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Labcorp
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
11 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

BrightSpring Health Services beats Labcorp on 10 of the 17 factors compared between the two stocks.

How does BrightSpring Health Services compare to Quest Diagnostics?

BrightSpring Health Services (NASDAQ:BTSG) and Quest Diagnostics (NYSE:DGX) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

88.1% of Quest Diagnostics shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by company insiders. Comparatively, 0.9% of Quest Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

BrightSpring Health Services currently has a consensus price target of $70.71, suggesting a potential upside of 18.50%. Quest Diagnostics has a consensus price target of $235.31, suggesting a potential downside of 1.95%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, equities analysts plainly believe BrightSpring Health Services is more favorable than Quest Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
18 Buy rating(s)
2 Strong Buy rating(s)
3.10
Quest Diagnostics
0 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.54

In the previous week, Quest Diagnostics had 5 more articles in the media than BrightSpring Health Services. MarketBeat recorded 17 mentions for Quest Diagnostics and 12 mentions for BrightSpring Health Services. Quest Diagnostics' average media sentiment score of 1.45 beat BrightSpring Health Services' score of 1.43 indicating that Quest Diagnostics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
11 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Quest Diagnostics
16 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Quest Diagnostics has a net margin of 9.18% compared to BrightSpring Health Services' net margin of 2.55%. BrightSpring Health Services' return on equity of 16.73% beat Quest Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.55% 16.73% 5.24%
Quest Diagnostics 9.18%16.01%7.27%

BrightSpring Health Services has a beta of 1.85, suggesting that its share price is 85% more volatile than the broader market. Comparatively, Quest Diagnostics has a beta of 0.55, suggesting that its share price is 45% less volatile than the broader market.

Quest Diagnostics has lower revenue, but higher earnings than BrightSpring Health Services. Quest Diagnostics is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$14.37B0.82$190.67M$1.6635.94
Quest Diagnostics$11.04B2.40$992M$9.4225.48

Summary

BrightSpring Health Services beats Quest Diagnostics on 9 of the 17 factors compared between the two stocks.

How does BrightSpring Health Services compare to Guardant Health?

BrightSpring Health Services (NASDAQ:BTSG) and Guardant Health (NASDAQ:GH) are both large-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.

BrightSpring Health Services presently has a consensus price target of $70.71, indicating a potential upside of 18.50%. Guardant Health has a consensus price target of $183.78, indicating a potential upside of 12.74%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, equities analysts plainly believe BrightSpring Health Services is more favorable than Guardant Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
18 Buy rating(s)
2 Strong Buy rating(s)
3.10
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
23 Buy rating(s)
1 Strong Buy rating(s)
2.96

BrightSpring Health Services has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$14.37B0.82$190.67M$1.6635.94
Guardant Health$982.02M22.28-$416.28M-$3.49N/A

In the previous week, Guardant Health had 8 more articles in the media than BrightSpring Health Services. MarketBeat recorded 20 mentions for Guardant Health and 12 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.43 beat Guardant Health's score of 1.03 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
11 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Guardant Health
13 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Positive

BrightSpring Health Services has a beta of 1.85, meaning that its stock price is 85% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.57, meaning that its stock price is 57% more volatile than the broader market.

BrightSpring Health Services has a net margin of 2.55% compared to Guardant Health's net margin of -38.33%. BrightSpring Health Services' return on equity of 16.73% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.55% 16.73% 5.24%
Guardant Health -38.33%N/A -25.40%

92.6% of Guardant Health shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by insiders. Comparatively, 5.6% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

BrightSpring Health Services beats Guardant Health on 12 of the 17 factors compared between the two stocks.

How does BrightSpring Health Services compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations, dividends and media sentiment.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to BrightSpring Health Services' net margin of 2.55%. BrightSpring Health Services' return on equity of 16.73% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.83% 9.28% 4.16%
BrightSpring Health Services 2.55%16.73%5.24%

Fresenius Medical Care AG & Co. KGaA presently has a consensus target price of $23.57, indicating a potential upside of 3.95%. BrightSpring Health Services has a consensus target price of $70.71, indicating a potential upside of 18.50%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, analysts clearly believe BrightSpring Health Services is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.55
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
18 Buy rating(s)
2 Strong Buy rating(s)
3.10

In the previous week, BrightSpring Health Services had 9 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 12 mentions for BrightSpring Health Services and 3 mentions for Fresenius Medical Care AG & Co. KGaA. BrightSpring Health Services' average media sentiment score of 1.43 beat Fresenius Medical Care AG & Co. KGaA's score of 1.36 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
11 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than BrightSpring Health Services. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$22.20B0.55$1.11B$1.9311.75
BrightSpring Health Services$14.37B0.82$190.67M$1.6635.94

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.85, suggesting that its share price is 85% more volatile than the broader market.

Summary

BrightSpring Health Services beats Fresenius Medical Care AG & Co. KGaA on 12 of the 17 factors compared between the two stocks.

How does BrightSpring Health Services compare to DaVita?

DaVita (NYSE:DVA) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

In the previous week, BrightSpring Health Services had 1 more articles in the media than DaVita. MarketBeat recorded 12 mentions for BrightSpring Health Services and 11 mentions for DaVita. DaVita's average media sentiment score of 1.48 beat BrightSpring Health Services' score of 1.43 indicating that DaVita is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DaVita
10 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
11 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

DaVita has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.85, meaning that its share price is 85% more volatile than the broader market.

DaVita currently has a consensus price target of $221.75, suggesting a potential upside of 23.59%. BrightSpring Health Services has a consensus price target of $70.71, suggesting a potential upside of 18.50%. Given DaVita's higher possible upside, equities research analysts clearly believe DaVita is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DaVita
1 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.38
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
18 Buy rating(s)
2 Strong Buy rating(s)
3.10

DaVita has a net margin of 6.05% compared to BrightSpring Health Services' net margin of 2.55%. BrightSpring Health Services' return on equity of 16.73% beat DaVita's return on equity.

Company Net Margins Return on Equity Return on Assets
DaVita6.05% -217.63% 5.07%
BrightSpring Health Services 2.55%16.73%5.24%

DaVita has higher earnings, but lower revenue than BrightSpring Health Services. DaVita is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DaVita$13.64B0.84$746.80M$12.2214.68
BrightSpring Health Services$14.37B0.82$190.67M$1.6635.94

90.1% of DaVita shares are held by institutional investors. 1.9% of DaVita shares are held by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

BrightSpring Health Services beats DaVita on 10 of the 17 factors compared between the two stocks.

Get BrightSpring Health Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTSG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BTSG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTSG vs. The Competition

MetricBrightSpring Health ServicesHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$12.05B$9.89B$7.21B$12.66B
Dividend YieldN/A2.57%2.53%8.56%
P/E Ratio36.6834.76272.6825.23
Price / Sales0.825.63630.59104.23
Price / Cash26.92121.2776.9852.08
Price / Book5.773.9812.996.10
Net Income$190.67M$310.54M$3.47B$348.86M
7 Day Performance-2.02%-0.77%-0.10%-1.90%
1 Month Performance-1.33%-0.11%6.76%1.96%
1 Year Performance147.79%15.07%25.09%15.30%

BrightSpring Health Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTSG
BrightSpring Health Services
4.7832 of 5 stars
$59.67
-1.0%
$70.71
+18.5%
+152.3%$12.05B$14.37B36.6823,500
LH
Labcorp
4.0756 of 5 stars
$329.53
-0.9%
$330.00
+0.1%
+21.3%$26.75B$13.95B27.2871,000
DGX
Quest Diagnostics
4.4771 of 5 stars
$238.04
-0.9%
$235.31
-1.1%
+35.0%$26.26B$11.04B25.2657,000
GH
Guardant Health
3.0184 of 5 stars
$163.55
+2.8%
$183.78
+12.4%
+145.2%$21.94B$982.02MN/A2,506
FMS
Fresenius Medical Care AG & Co. KGaA
3.3045 of 5 stars
$22.75
+0.1%
$23.57
+3.6%
-6.8%$12.21B$22.20B11.781,488

Related Companies and Tools


This page (NASDAQ:BTSG) was last updated on 9/3/2026 by MarketBeat.com Staff.
From Our Partners